Irving E Salit

Summary

Affiliation: University of Toronto
Country: Canada

Publications

  1. ncbi request reprint The role of cytology (Pap tests) and human papillomavirus testing in anal cancer screening
    Irving E Salit
    University Health Network, Toronto General Hospital, Ontario, Canada
    AIDS 24:1307-13. 2010
  2. pmc Ano-genital human papillomavirus type 97 infection is detected in Canadian men but not women at risk or infected with the human immunodeficiency virus
    Marie Ève Landry
    Departement de Pathologie, Centre Hospitalier de l Universite de Montreal, Montreal, Quebec, Canada
    Virol J 9:243. 2012
  3. doi request reprint A possible cluster of sexually transmitted Entamoeba histolytica: genetic analysis of a highly virulent strain
    Irving E Salit
    Division of Infectious Diseases, Department of Medicine, University Health Network, Toronto General Hospital, Toronto, Ontario, Canada
    Clin Infect Dis 49:346-53. 2009
  4. pmc Travel patterns and risk behaviour of HIV-positive people travelling internationally
    Irving E Salit
    Faculty of Medicine, University of Toronto, ON
    CMAJ 172:884-8. 2005
  5. doi request reprint Screening for HIV-associated anal cancer: correlation of HPV genotypes, p16, and E6 transcripts with anal pathology
    Irving E Salit
    University Health Network, Toronto General Hospital, Toronto, Ontario, Canada
    Cancer Epidemiol Biomarkers Prev 18:1986-92. 2009
  6. ncbi request reprint Interobserver agreement in the interpretation of anal intraepithelial neoplasia
    Alice Lytwyn
    Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada
    Cancer 103:1447-56. 2005
  7. ncbi request reprint Non-alcoholic fatty liver disease in HIV infection associated with altered hepatic fatty acid composition
    Bianca M Arendt
    University Health Network, Dept of Medicine, Toronto, Ontario, Canada
    Curr HIV Res 9:128-35. 2011
  8. doi request reprint Cost-effectiveness of screening for anal precancers in HIV-positive men
    Jonathan M C Lam
    University of Toronto, Toronto General Hospital, Canada
    AIDS 25:635-42. 2011
  9. ncbi request reprint In patients with HIV-infection, chromium supplementation improves insulin resistance and other metabolic abnormalities: a randomized, double-blind, placebo controlled trial
    Elaheh Aghdassi
    The University Health Network, The Toronto General Hospital, 200 Elizabeth St 9 N 973, Toronto, Ontario M5G2C4, Canada
    Curr HIV Res 8:113-20. 2010
  10. ncbi request reprint A survey on the usage of supplements in canadian patients living with HIV
    Elaheh Aghdassi
    The University Health Network, The Toronto Western Hospital, Toronto, Ontario, Canada
    Curr HIV Res 7:555-61. 2009

Collaborators

Detail Information

Publications18

  1. ncbi request reprint The role of cytology (Pap tests) and human papillomavirus testing in anal cancer screening
    Irving E Salit
    University Health Network, Toronto General Hospital, Ontario, Canada
    AIDS 24:1307-13. 2010
    ..To assess anal oncogenic human papillomavirus (HPV) and anal cytology as screening tests for detecting high-grade anal intraepithelial neoplasia (AIN 2+), as this is an immediate anal cancer precursor...
  2. pmc Ano-genital human papillomavirus type 97 infection is detected in Canadian men but not women at risk or infected with the human immunodeficiency virus
    Marie Ève Landry
    Departement de Pathologie, Centre Hospitalier de l Universite de Montreal, Montreal, Quebec, Canada
    Virol J 9:243. 2012
    ..The prevalence of human papillomavirus type 97 (HPV97) was assessed in cervicovaginal cells from women living in Canada and in anal samples from HIV-seropositive men living in Toronto...
  3. doi request reprint A possible cluster of sexually transmitted Entamoeba histolytica: genetic analysis of a highly virulent strain
    Irving E Salit
    Division of Infectious Diseases, Department of Medicine, University Health Network, Toronto General Hospital, Toronto, Ontario, Canada
    Clin Infect Dis 49:346-53. 2009
    ..Epidemiologically linked clusters of E. histolytica infection are rare in industrialized countries. We report such a sexually linked cluster in Canada...
  4. pmc Travel patterns and risk behaviour of HIV-positive people travelling internationally
    Irving E Salit
    Faculty of Medicine, University of Toronto, ON
    CMAJ 172:884-8. 2005
    ..These risks are even higher among immunocompromised people, such as those with HIV infection. We conducted a study to determine HIV-positive people's travel patterns and risk behaviours while abroad...
  5. doi request reprint Screening for HIV-associated anal cancer: correlation of HPV genotypes, p16, and E6 transcripts with anal pathology
    Irving E Salit
    University Health Network, Toronto General Hospital, Toronto, Ontario, Canada
    Cancer Epidemiol Biomarkers Prev 18:1986-92. 2009
    ..HIV-positive men with a history of anal-receptive intercourse are at risk for anal cancer. We determined whether human papilloma virus (HPV) biomarkers were correlated with anal pathology in these men...
  6. ncbi request reprint Interobserver agreement in the interpretation of anal intraepithelial neoplasia
    Alice Lytwyn
    Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada
    Cancer 103:1447-56. 2005
    ..Screening for AIN using anal cytology was suggested. The authors evaluated agreement on cytologic and biopsy specimens from HIV-positive men undergoing anal carcinoma screening...
  7. ncbi request reprint Non-alcoholic fatty liver disease in HIV infection associated with altered hepatic fatty acid composition
    Bianca M Arendt
    University Health Network, Dept of Medicine, Toronto, Ontario, Canada
    Curr HIV Res 9:128-35. 2011
    ..Changes may be due to impaired FA metabolism or suboptimal n-3 PUFA intake. The potential role of n-3 PUFA (e.g. fish oil) to treat or prevent HIV/NAFLD warrants further investigation...
  8. doi request reprint Cost-effectiveness of screening for anal precancers in HIV-positive men
    Jonathan M C Lam
    University of Toronto, Toronto General Hospital, Canada
    AIDS 25:635-42. 2011
    ..To assess the cost-effectiveness of high-resolution anoscopy (HRA), anal cytology, and anal human papillomavirus (HPV) detection in screening for histologic high-grade anal intraepithelial neoplasia (AIN 2/3) in HIV-positive MSM...
  9. ncbi request reprint In patients with HIV-infection, chromium supplementation improves insulin resistance and other metabolic abnormalities: a randomized, double-blind, placebo controlled trial
    Elaheh Aghdassi
    The University Health Network, The Toronto General Hospital, 200 Elizabeth St 9 N 973, Toronto, Ontario M5G2C4, Canada
    Curr HIV Res 8:113-20. 2010
    ..In summary, chromium improved insulin resistance, metabolic abnormalities, and body composition in HIV+ patients. This suggests that chromium supplements alleviate some of the antiretroviral-associated metabolic abnormalities...
  10. ncbi request reprint A survey on the usage of supplements in canadian patients living with HIV
    Elaheh Aghdassi
    The University Health Network, The Toronto Western Hospital, Toronto, Ontario, Canada
    Curr HIV Res 7:555-61. 2009
    ....
  11. ncbi request reprint Estimation of body fat mass using dual-energy x-ray absorptiometry, bioelectric impedance analysis, and anthropometry in HIV-positive male subjects receiving highly active antiretroviral therapy
    Elaheh Aghdassi
    University of Toronto, Toronto, Ontario, Canada
    JPEN J Parenter Enteral Nutr 31:135-41. 2007
    ..As different patterns of abdominal fat accumulation might affect the body FM estimation, correlation and agreement of these methods were also compared in patients with waist to hip ratio (WHR) < or =0.9 and >0.9...
  12. doi request reprint Cohort profile: the Ontario HIV Treatment Network Cohort Study (OCS)
    Sean B Rourke
    Ontario HIV Treatment Network, Toronto, ON, Canada
    Int J Epidemiol 42:402-11. 2013
    ..Interested collaborators are encouraged to submit analysis project proposals as instructed on the study website (www.ohtncohortstudy.ca)...
  13. ncbi request reprint Significant interaction between activated charcoal and antiretroviral therapy leading to subtherapeutic drug concentrations, virological breakthrough and development of resistance
    Alice L Tseng
    Immunodeficiency Clinic, Toronto General Hospital, Toronto, ON, Canada
    Antivir Ther 18:735-8. 2013
    ..According to the drug interaction probability scale, our patient experienced a probable drug interaction between activated charcoal and atazanavir/ritonavir leading to virological breakthrough and development of resistance. ..
  14. ncbi request reprint HIV-positive patients with nonalcoholic fatty liver disease have a lower body mass index and are more physically active than HIV-negative patients
    Saira S Mohammed
    Department of Medicine, University Health Network, University of Toronto, 200 Elizabeth Street, Toronto, Ontario, Canada
    J Acquir Immune Defic Syndr 45:432-8. 2007
    ..To determine whether the clinical and metabolic features associated with nonalcoholic fatty liver disease (NAFLD) are similar between HIV-positive and HIV-negative male subjects...
  15. ncbi request reprint Is chromium an important element in HIV-positive patients with metabolic abnormalities? An hypothesis generating pilot study
    Elaheh Aghdassi
    Department of Medicine, The University Health Network, The Toronto General Hospital, 200 Elizabeth St, Eaton Wing, 9 Floor, Room 217a, Toronto, Ontario, M5G 2C4, Canada
    J Am Coll Nutr 25:56-63. 2006
    ..Chromium plays a role in insulin sensitivity...
  16. doi request reprint 38. Anal cancer screening in HIV primary care: uptake and outcomes
    Irving E Salit
    University Health Network, Toronto, ON, Canada
    Sex Health 10:588. 2013
    ..Most with HSIL had histological high-grade disease and were treated. IRC was more successful than TCA at ablating high-grade disease. ..
  17. ncbi request reprint CD4+ cell count decline despite HIV suppression: a probable didanosine-valganciclovir interaction
    Alice L Tseng
    Immunodeficiency Clinic, Toronto General Hospital, Toronto, Ontario, Canada
    Ann Pharmacother 41:512-7. 2007
    ..To describe a case of significant CD4+ cell decline despite complete viral suppression in an HIV-positive patient receiving didanosine and valganciclovir...
  18. ncbi request reprint Long-term quality-of-life outcomes among adults living with HIV in the HAART era: the interplay of changes in clinical factors and symptom profile
    Robert W Burgoyne
    Immunodeficiency Clinic, Toronto General Hospital, Ontario, Canada
    AIDS Behav 8:151-63. 2004
    ..CD4 repletion offset negative effects of symptoms for some aspects of quality of life. The long-term course of quality of life was somewhat predicted by viral load suppression due to the conjoint influence of symptoms and CD4 count...